Bernard Vandercam

1.4k citations
25 papers · 1.2k · 1 hit paper · h-index 12

Impact in

  • Microbiology top 0.5%
    • Actinomycetales infections and treatment
    • Antimicrobial Resistance in Staphylococcus
    • Antifungal resistance and susceptibility
    • HIV/AIDS drug development and treatment
    • Clostridium difficile and Clostridium perfringens research

Papers in

    • HIV/AIDS drug development and treatment 7
    • Antifungal resistance and susceptibility 3
    • Antimicrobial Resistance in Staphylococcus 2
    • Dialysis and Renal Disease Management 2

Bernard Vandercam

25 papers receiving 1.1k citations

Bernard Vandercam's Hit Papers

Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study 2016 · 196 citations
1960+3+6Years since publication50100150

Peers

Bernard Vandercam
Comparison fields: 5 of 59
  • Microbiology 154
  • Infectious Diseases 723
  • Clinical Biochemistry 42
  • Molecular Medicine 26
  • Virology 17
Replace Edina H Moylett with:
Edina H Moylett United States
Ramon Del Busto United States
Elena N. Beam United States
Tirdad T. Zangeneh United States
Dennis J. Cleri United States
William A. Causey United States
Frederick P. Duncanson United States
Michael C. Bach United States
Daniel Christmann France
Valerie J. Robertson Zimbabwe
Bernard Vandercam relative to Edina H Moylett United States Edina H Moylett's profile →
Citations per field
00.5×2×4×6×7×
Edina H Moylett · 1×
Citations per year

Countries citing papers authored by Bernard Vandercam

Since Specialization
Citations

This map shows the geographic impact of Bernard Vandercam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Vandercam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Vandercam more than expected).

Fields of papers citing papers by Bernard Vandercam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Vandercam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Vandercam. The network helps show where Bernard Vandercam may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernard Vandercam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard Vandercam Line = papers co-authored together Bernard Vandercam links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1995261
2 1998205
3
Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study
Hit paper breakdown →
2016196
4 201782
5 198766
6
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
198756
7 199653
8 199952
9 202244
10 199943
11 200538
12 200424
13
Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.
200512
14 20098
15 20007
16 20127
17 19896
18 20066
19
Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients
19965
20
HIV infection and rape.
19924

About Bernard Vandercam

Bernard Vandercam is a scholar working on Infectious Diseases, Nephrology, Emergency Medicine, Epidemiology and Microbiology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), Antifungal resistance and susceptibility (3 papers), HIV-related health complications and treatments (2 papers), Dialysis and Renal Disease Management (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Neutropenia and Cancer Infections (2 papers), Autoimmune and Inflammatory Disorders (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Microbiology (154 citations), Infectious Diseases (723 citations), Clinical Biochemistry (42 citations), Molecular Medicine (26 citations) and Virology (17 citations). Bernard Vandercam has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Michel Delmée, Jean‐Luc Gala, Pascal Vannuffel, G. Wauters, Jacques Gigi, H Ezzedine, Eric Jean Goffin, V. Avesani, J. L. Michaux and Jacques F. G. M. Meis. Their work appears in journals such as Clinical Infectious Diseases, Antiviral Therapy, American Journal of Kidney Diseases, Research in Microbiology and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact